QID 240471

Date Published: 2022-06-16

QID 240471: Red Hat Update for .net core 3.1 (RHSA-2022:5061)

.net is a managed-software framework.
It implements a subset of the .net framework apis and several new apis, and it includes a clr implementation.

Security Fix(es):

dotnet: nuget credential leak due to loss of control of third party symbol server domain (cve-2022-30184)

Affected Products:

Red Hat enterprise linux for x86_64 8 x86_64
Red Hat enterprise linux for x86_64 - extended update support 8.6 x86_64
Red Hat enterprise linux server - aus 8.6 x86_64
Red Hat enterprise linux server - tus 8.6 x86_64
Red Hat enterprise linux for x86_64 - update services for sap solutions 8.6 x86_64
Red Hat codeready linux builder for x86_64 8 x86_64
Red Hat codeready linux builder for x86_64 - extended update support 8.6 x86_64

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

CVSS V3 rated as Medium - 5.5 severity.

CVSS V2 rated as Medium - 5.4 severity.

Solution

Refer to Red Hat security advisory RHSA-2022:5061 for updates and patch information.

Vendor References

RHSA-2022:5061 - access.redhat.com/errata/RHSA-2022:5061

CVEs related to QID 240471

CVE-2022-30184 |

Software Advisories

Advisory ID	Software	Component	Link
RHSA-2022:5061	Red Hat Enterprise Linux		access.redhat.com/errata/RHSA-2022:5061

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].